Countries in the former Soviet Union (FSU) are encountering a rapidly increasing burden of HIV/AIDS, particularly among difficult-to-reach groups such as injecting drug users and commercial sex workers. Unfortunately, the high cost of many antiretroviral (ARV) medicines limits the ability of governments to purchase enough ARVs to treat HIV/AIDS.
This report, conducted by the Boston University School of Public Health and funded in part by OSI, benchmarks ARV prices of FSU countries against each other and against global and European region ARV prices. The study reveals that extreme price variation exists within and across FSU countries for identical ARVs, which suggests that some countries may be able to obtain ARVs at lower prices and therefore purchase additional ARVs to treat more people.
Download
-
Benchmarking Antiretroviral Prices in Countries of the Former Soviet Union (English) (271.32 Kb pdf file)
Download the complete report in English.
-
Benchmarking Antiretroviral Prices in Countries of the Former Soviet Union (Russian) (580.16 Kb pdf file)
Download the complete report in Russian.
Read more
Vaccine Justice
The Quest to Boost Africa’s Fight Against COVID-19
While Africa consumes 25 percent of the world’s vaccines, only one percent of vaccines are manufactured there. The mRNA vaccine manufacturing hub in South Africa is working to change that.
Rest in Peace
Remembering David Rothman, a Liberator and Pioneer
Rothman, a scholar-advocate of the highest order who had a profound influence on Open Society, wrote on a wide array of subjects concerning ethics and medicine, and helped free thousands of people from involuntary institutionalization.
Valuing Lived Experience
The Need for a Human Rights-Based Approach to Global Mental Health
A growing body of research shows that Western models of mental health don’t work for everyone. When it comes to care or policy, policymakers should first listen to those with lived experience of mental health challenges.